The induction and maintenance of T cell memory is critical to the success of vaccines. A recently described subset of memory CD8 + T cells defined by intermediate expression of the chemokine receptor CX3CR1 was shown to have self-renewal, proliferative, and tissue-surveillance properties relevant to vaccine-induced memory. We tracked these cells when memory is sustained at high levels: memory inflation induced by cytomegalovirus (CMV) and adenovirus-vectored vaccines. In mice, both CMV and vaccine-induced inflationary T cells showed sustained high levels of CX3R1 int cells exhibiting an effector-memory phenotype, characteristic of inflationary pools, in early memory. In humans, CX3CR1 int CD8 + T cells were strongly induced following adenovirus-vectored vaccination for hepatitis C virus (HCV) (ChAd3-NSmut) and during natural CMV infection and were associated with a memory phenotype similar to that in mice. These data indicate that CX3CR1 int cells form an important component of the memory pool in response to persistent viruses and vaccines in both mice and humans.
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In Brief
Gordon et al. demonstrate that CX3CR1 int peripheral memory T cells are a substantial component of memory inflation induced by persistent CMVs and adenoviral vaccination. They are characterized by sustained proliferation and an effector-memory phenotype linked to these expanded CD8+ T cell memory responses. Core phenotypic features are shared by humans and mice.
INTRODUCTION
During an infection, naive T cells become activated and proliferate upon recognition of cognate antigen, giving rise to effector subsets. While effector T cell populations contract following control of infection, a fraction persists as diverse long-lived memory T (Tmem) cells. Tmem cells are heterogeneous subsets defined by homing receptor expression and tissue localization. Traditionally, two major Tmem subsets in blood were defined based on expression of lymph node homing receptors CCR7 and CD62L, denoting CCR7 + /CD62L + central-memory (TCM) cells, with the capacity to migrate to lymphoid tissues, and CCR7
À /CD62L
À effector-memory (TEM) cells, which are able to migrate to peripheral tissues (Sallusto et al., 1999) . TCM cells have superior ability to produce interleukin-2 (IL-2), proliferate and persist within the host, and become the predominant memory CD8 + T cell subset over time (Wherry et al., 2003) . By comparison, TEM cells are more cytotoxic, migrate to diverse peripheral tissues sites, and until recently, were thought to be the dominant subset performing tissue surveillance (Sallusto et al., 1999) . Recently identified, non-migratory tissue-resident memory (TRM) cells, a third Tmem subset, are localized in diverse tissue sites and mediate local protective immune responses (Mueller and Mackay, 2016) . Gerlach et al. (2016) identified a fourth Tmem subset, peripheral memory (TPM) cells, which are defined by intermediate levels of expression of the chemokine receptor CX3CR1 (Fractalkine receptor). Using Cx3cr1 +/gfp+ reporter mice infected with lymphocytic choriomeningitis virus (LCMV) or vaccinia virus, Gerlach et al. (2016) showed that CX3CR1 int TPM cells, rather than CX3CR1 hi TEM cells, are the predominant migratory Tmem cells that survey peripheral tissues. In addition, CX3CR1 int TPM cells have superior homeostatic proliferation capacity compared with other Tmem subsets and not only self-renew but also contribute to the expanding CX3CR1 neg TCM pool. The identification of CX3CR1 int TPM cells necessitates re-examination of the roles that different CD8 + T cell subsets play in immunosurveillance and protection against re-infection to a variety of pathogens. CD8 + T cells are crucial for the immune response to infections and cancer, and eliciting large and persistent effector T cell populations has been the focus of vaccine development. The role of CX3CR1 int TPM cells in the generation and maintenance of robust vaccine-derived Tmem populations is yet to be fully explored. Cytomegalovirus (CMV) and adenoviral vectors induce an expanded, sustained TEM CD8 + T cell response to specific epitopes, termed memory inflation, leading to interest in these cells as vaccine modalities (Klenerman and Oxenius, 2016) . Inflationary T cells maintain effector function and ability to proliferate but lack features of T cell exhaustion (Klenerman and Oxenius, 2016) . CMV infection in mice and humans (MCMV and HCMV, respectively) can lead to single-specificity inflationary T cells comprising of up to 20% of the circulating T cell pool, which develop in parallel with conventional non-inflating TCM responses to many epitopes (Karrer et al., 2003) . Preclinical models of HIV vaccines using simian CMV vectors show promise and generate atypical major histocompatibility complex (MHC) class II and human leukocyte antigen (HLA)-E-restricted CD8 + T cell responses (Hansen et al., 2011 (Hansen et al., , 2016 . Adenoviral vector-induced T cell responses in a murine model using a recombinant replicationdeficient human adenovirus 5 (HuAd5) vector expressing b-galactosidase (Ad-lacZ) led to memory inflation of T cell responses to one of two immunodominant epitopes (Bolinger et al., 2013) . Clinical studies of replication-deficient adenoviral vectors have shown potency in generation of antiviral T cell pools with features that overlap with those of inflated populations in MCMV and HCMV infection (Bolinger et al., 2015; Swadling et al., 2014) . Understanding induction and maintenance of robust T cell memory is important for the development of CD8 + T cells vaccines that aim to induce large numbers of memory CD8 + T cells of a favorable phenotype able to provide optimal protection against complex pathogens. However, the phenotype of the memory cells that maintain large CD8 + T memory pools remains incompletely defined (Klenerman and Oxenius, 2016) . The identification of CX3CR1 int TPM cells with enhanced self-renewal and proliferative
properties (Gerlach et al., 2016) Figure S1 ) (Bolinger et al., 2015) . Conventional memory responses in the MCMV model provide an internal control for analysis of the inflating memory response, because variables such as viral replication and antigen persistence are identical. CX3CR1 expression levels distinguished three virus-specific CD8 + Tmem subsets (CX3CR1 Table S3 ), while uninfected C57BL/6 mice were devoid of CD8 + T cells expressing CX3CR1
( Figure S2A ). To further characterize CX3CR1 expression, we used Cx3cr1 +/gfp+ reporter mice in which GFP was introduced into the Cx3cr1 locus. Following i.v. injection of 10 6 PFU (high dose) MCMV, three subsets based on CX3CR1 expression levels were distinguished in conventional and inflating CD8 + Tmem responses in blood ( Figure 1A ). GFP-expressing CD8 + T cells were absent from uninfected Cx3cr1 +/gfp+ mice ( Figure S2A ) (Bö ttcher et al., 2015; Gerlach et al., 2016) . The frequency distribution of MCMV-specific CX3CR1 int and CX3CR1 hi Tmem cells differed in C57BL/6 mice compared to Cx3cr1 +/gfp+ mice ( Figure S2C ), likely reflecting the transient surface expression of CX3CR1 on C57BL/6 mice and the sustained fluorescence of GFP (half-life > 24 hr), which is unaffected by CX3CR1 internalization (Jung et al., 2000 (Gerlach et al., 2016) . To address whether the infective dose influences CX3CR1 expression, we assessed CX3CR1 expression in Cx3cr1 +/gfp+ mice infected i.v. with 2,000 PFU (low dose) MCMV (Figures 1A and 1B) . Again, conventional Tmem populations maintained high mean frequencies of CX3CR1 int cells (24%-44%), and Tmem switched to predominantly CX3CR1 neg cells at later memory time points, in keeping with conventional memory responses following acute viral infection (Gerlach et al., 2016) . In comparison, inflationary Tmem cells during persistent MCMV infection were nearly all CX3CR1 positive (int and hi) (Figures 1A and 1B) , consistent with previous reports (Bolinger et al., 2015 
CX3CR1
int CD8 + T Cells Retain a TEM Phenotype during Memory Inflation We next asked whether tissue homing, activation state, or maintenance profile differed among CX3CR1 subsets in Tmem cells in blood following MCMV infection. We examined lymph node homing based on L-selectin (CD62L), differentiation based on CD27, and the homeostatic cytokine interleukin-7 receptor (IL-7R) CD127. CD27 is upregulated during the first days after T cell receptor activation and downregulated during T cell effector differentiation (Hintzen et al., 1993) . CD127 expression is downregulated by activated effector T cells (Kiazyk and Fowke, 2008) and on inflationary CD8 + T cells following response to IL-7 (Bolinger et al., 2013) . Previous study of Tmem cells using acute viral infection models (Gerlach et al., 2016) Figure 1D ; Figure S2I ), and CD27 and CD127 expression on CX3CR1 int cells decreased over time (Figures 1C and 1D; Figures S2E and S2F) . Our results suggest that in persistent MCMV infection, the overall phenotype of CX3CR1 int cells is that of an TEM pool, reflecting the well-described features associated with this setting of persistent infection and antigen exposure. Nevertheless, even within the TEM pool, they showed some delayed differentiation compared to CXC3R1 hi counterparts ( Figure 1D ; Figure S2F ).
int CD8 + T Cells Are Induced by a Nonreplicating Adenovirus Vector To further explore the contribution of viral replication and/or antigen persistence to the distribution and phenotype of CX3CR1 Tmem subsets, we examined the qualities of vaccine-induced responses following administration of a recombinant replication-deficient Ad-lacZ (Bolinger et al., 2013) . Ad-lacZ immunization induces two distinct pathways for memory: a typical contracting response to a one epitope (I8V) and an inflating response to second epitope (D8V), which is analogous to conventional (M45) and inflating (M38) responses to MCMV infection (Bolinger et al., 2013) Figure S3B ), consistent with previous reports (Bolinger et al., 2015) . In the early memory phase, more conventional I8V-tetramer + cells were CX3CR1 positive compared to M45-tetramer cells, which may reflect continued presentation of I8V antigen in the Ad-lacZ model. Similar to MCMV infection, Ad-lacZ-derived conventional and inflating Tmem populations contained significant frequencies of CX3CR1 int cells (ranges 22%-86% and 21%-94%, respectively) during the early memory phase (21-89 dpi) ( Figure 2B ), which had a TEM phenotype (CD62L , and S3F). The spleen, liver, and lungs are sites of viral amplification in acute MCMV infection and contain higher viral titers than the blood (Vliegen et al., 2003 infection with low-dose MCMV resulted in some CX3CR1 int cells in the inflating population ( Figure 3A ). As in MCMV infection, following AdlacZ vaccination, CX3CR1 int conventional and inflating Tmem cells were largely absent from tissues yet were present in the blood at similar time points ( Figure 3B ). Using in vivo antibody labeling to identify extravascular (i.e., unlabeled by i.v. antibody) Tmem cells ( Figure 3C ), conventional tissue Tmem cells were mostly CX3CR1 neg , as reported previously (Gerlach et al., 2016) , and inflating tissue Tmem cells were mostly CX3CR1 hi ( Figures 3D and 3E ). Most I8V-and D8V-tetramer + cells in the liver were accessible to the circulation (i.v.) ( Figures 3C and 3D ) yet had high expression (82%-98%, n = 3) of the intracellular adhesion molecule 1 (ICAM-1) ligand leukocyte function-associated antigen 1 (LFA-1) ( Figure S3F ), regardless of CX3CR1 subset. LFA-1 expression has been shown to allow liver-resident Tmem to patrol and remain in hepatic sinusoids (McNamara et al., 2017) . As has been reported (Smith et al., 2015) , lung inflationary Tmem cells (M38-and D8V-tetramer + ) did not express the tissue-resident markers CD69 and CD103 ( Figure S2H ). Ad-lacZ DNA and RNA can be isolated from spleen, liver, and lung at day 100 post-immunization (Bolinger et al., 2013) , suggesting that vaccine antigen may be present in tissues a long time after immunization. Altogether, the similarities of CX3CR1 subset distribution and phenotype between persistent MCMV infection and immunization with a non-replicative adenoviral vector support the role of antigen persistence rather than viral replication in determining the expression and phenotype of CX3CR1 subsets on Tmem cells.
CX3CR1 Is Required for Optimal Inflating T Cell Memory Responses following Ad-lacZ Immunization
The previous study has indicated that CX3CR1 is not required for antigen recognition or effector differentiation following acute viral infection (Gerlach et al., 2016) . We next explored whether CX3CR1 is required for Tmem development in persistent MCMV infection and/or immunization with Ad-lacZ. We used Cx3cr1 gfp+/gfp+ mice in which GFP was knocked in to both Cx3cr1 loci; therefore, functional CX3CR1 protein is not expressed. Mice were infected with high-dose MCMV, low-dose MCMV, or Ad-lacZ, as described previously. Cx3cr1 gfp+/gfp+ mice generated robust conventional and inflating Tmem responses in blood ( Figures 4A and 4B ) and tissues ( Figure S4B ) following high-and low-dose MCMV infection with similar CX3CR1 subset distribution to that of Cx3cr1 +/gfp+ mice ( Figures   S4A and S4C ). In contrast, CX3CR1 was required for optimal magnitude of inflating (D8V + ) Tmem responses, but not conventional (I8V + ) Tmem responses, following Ad-lacZ immunization in blood ( Figure 4C ) and tissues ( Figure 4D Figure 4G ) and decreased KLRG1 (Figure 4H ) expression over time in CX3CR1 int subsets. CX3CR1-expressing macrophages are thought to be involved in the spread of MCMV (Daley-Bauer et al., 2014) ; however, because differences were not observed in the conventional memory (M45-and I8V-tetramer + ) populations, which act as an internal control (Figures 4A-4F ; Figure S4 ), viral spread in Cx3cr1 gfp+/gfp+ mice is likely to be preserved. No differences were observed in the number of CD8 + T cells in tissues between Cx3cr1 +/gfp+ and Cx3cr1 gfp+/gfp+ mice, indicating that T cell localization remains intact (Table S1 ). These results suggest that CX3CR1 is not required for memory inflation but is required for optimal responses and effector differentiation of inflating vaccine-derived Tmem cells.
Distribution and Phenotype of Three CX3CR1 Subsets in Human CD8 + T Cells
We next addressed whether such changes in CX3CR1 expression and phenotype can be observed in human memory pools induced by CMV and adenoviral vectors. There are limited human data describing the distribution and phenotype of CX3CR1 subsets in polyclonal CD8 + T cells. To address this knowledge gap, we first focused on whether CX3CR1 expression can distinguish three CD8 + Tmem cell subsets in humans by analyzing peripheral blood mononuclear cells from 13 volunteers aged 21-54 years (Table S2 ). Samples were collected as part of adenoviral-vaccine studies (n = 10) or from healthy volunteers (n = 3). Polyclonal CD8 + T cell subset distribution and CX3CR1 expression did not differ during the vaccine study, and the end-of-study (EOS) sample was used for analysis. CX3CR1 expression levels distinguished three CX3CR1 subsets (neg, int, and hi) on bulk CD8 + T cells ( Figure 5A ; Figure Figure 7F ) (Wong et al., 2016) .
Human Adenoviral Vaccine and Persistent CMV Infection Induce CX3CR1
int Antigen-Specific CD8 + Tmem Cells To assess how CX3CR1 subsets on Tmem cells relate to persistent infection and adenoviral-vaccine-induced responses in humans, we analyzed (1) CD8 + T cells primed using a chimpanzee adenovirus strategy (ChAd3-NSmut), specific for dominant HCV epitopes from NS3 (NS395, HLA-A2 restricted, and NS3103, HLA-A1 restricted) (Swadling et al., 2014) , and (2) CMV-specific CD8 + T cells.
CX3CR1 expression was assessed in adenoviral vaccineinduced CD8
+ T cells in blood obtained from 9 volunteers, aged 21-54 years (Table S2 ). All volunteers received a priming regimen of ChAd3-NSmut (5 3 10 8 -2.5 3 10 10 viral particles) encoding the NS3, NS4, NS5A, and NS5B proteins of HCV genotype 1b ( Figure S5B ) (Swadling et al., 2014) . A subset of 5 volunteers also received a boost with a modified vaccinia Ankara (MVA)-NSmut (2 3 10 7 -2 3 10 8 PFU) vector encoding the same HCV genotype 1b proteins 8 weeks later ( Figure S5 ; Table S2 ). Blood samples were taken at peak response after ChAd3-NSmut prime (trial weeks [TW] 2-4, prime), peak response after MVA-NSmut boost (TW9, boost), and at end of study (EOS) (TW16-TW32). Peak vaccine responses were determined by ELISpot as described previously (Swadling et al., 2014) . Vaccine-derived CD8 + T cells were assessed by staining with HLA-A2 pentamers containing an NS3 epitope (A2-NS3 pentamer) (Table S3 ). All volunteers had detectable A2-NS3 pentamer + T cells (defined as R0.10% CD8 + T cells) after priming, which increased in frequency following MVA boost and contracted by EOS ( Figure 6A ), as reported previously (Swadling et al., 2014) . No differences in NS3 pentamer + CX3CR1 subsets were observed at EOS in those that received MVA boost and those that did not ( Figure S5C ), and both groups were combined for the EOS analysis. NS3 pentamer + T cells were predominantly TEM cells following prime and boost immunization, with TEMRA cells becoming more prevalent by EOS ( Figure 6B ) (Swadling et al., 2014 (Swadling et al., 2014) . We next assessed CX3CR1 expression in CMV-specific CD8 + T cells in blood obtained from 6 volunteers, aged 21-54 years (Table S2 ). Three volunteers also received the adenovirus vaccine, and their EOS sample was used for the CMV analysis (no difference was observed in CMV tetramer + T cells and CX3CR1 expression at any trial time point) (data not shown). CMV-specific T cells were identified by staining with HLAmatched tetramers or pentamers containing immunodominant CMV epitopes (Table S3) . CMV tetramer + CD8 T cells were mostly CX3CR1 int (26%) or CX3CR1 hi (61%) (Figures 7A-7C ).
Analysis of phenotypic markers CD27 and CD127 and transcription factors T-bet and Eomes ( Figures 7D and 7E ) revealed heterogenous expression patterns that were not related to magnitude of CMV tetramer + response or dominance of TEM or TEMRA response. These results suggest that CX3CR1 expression and phenotype on CMV-specific T cells form a dynamic process responsive to an individuals' CMV latency and reactivation events.
DISCUSSION
The induction and maintenance of robust CD8 + T cell memory are important for the control of persistent infection and critical to the success of vaccines against infections and cancers. (E and F) CX3CR1 subset expression of cell surface markers (CD27 and CD127) and transcription factors (T-bet, Eomes) in CD8 + Tmem cells.
(E) Composite FACS plots (n = 5) (L to R) of CD27, CD127, T-bet, and Eomes expression by CX3CR1 subsets on TCM, TEM, and TEMRA CD8 + T cells. Mean expression for each CX3CR1 subset is indicated (n = 13).
(F) Individual and mean CX3CR1 subset expression (L to R) of CD27, CD127, T-bet, and Eomes in TCM, TEM, and TEMRA CD8 + T cells (n = 13).
SSDs were determined by two-way ANOVA and corrected for multiple comparisons (Holm-Sidak). *p = 0.05 to 0.011, **p = 0.01 to 0. 001, ***p < 0.001. Data are compiled from a single experiment. See also Figure S5 . Gerlach et al. (2016) . Previous data have indicated that inflationary memory cells are derived from the TCM pool (Smith et al., 2014) . Our data suggest that CX3CR1 int cells, either derived from CX3CR1 neg TCM or self-renewing, contribute to stably maintaining the expanding size and effector phenotype of the inflating memory population ( Figure 7F ).
The initial sustained inflating CX3CR1 int response observed in our models is likely linked to low-level antigen persistence, possibly by presentation on non-professional antigen-presenting cells (APCs). The current model for memory inflation involves repetitive antigen presentation occurring on non-classical APCs, potentially in the vascular endothelium or a non-hematopoietic lymph node cell (Smith et al., 2014; Torti et al., 2011) . To support the role of low-level antigen persistence in inducing inflating CX3CR1 int cells, we found that (1) by reducing the infecting dose of MCMV, circulating inflating CX3CR1 int cells became even more frequent; (2) in tissues where viral replication is amplified-and to lesser extent, when a reduced infecting dose was used-CX3CR1 hi inflating cells remained dominant; and (3) inflating CX3CR1 int Tmem cells have a TEM phenotype similar to their CX3CR1 hi inflating counterparts, suggesting ongoing antigen exposure. Preservation of these characteristics in the inflating memory pool induced by a non-replicating Ad-lacZ vaccine supports the notion that persistent antigen exposure, rather than viral replication, promotes CX3CR1 int expression and phenotype. Conversely, the waning of the CX3CR1 int population at late time points may be due to a loss of antigen exposure. Gerlach et al. (2016) (Swadling et al., 2014) . Tmem cells expressing CX3CR1 are mostly absent from patients with chronic HCV infection, and the few present have markers of cytotoxicity (Bö ttcher et al., 2015) . In combination with the previously reported qualities of self-renewal, maintenance of memory pools, and tissue surveillance, CX3CR1 int cells may improve efficacy and endurance of CD8 + T cells vaccine responses.
CX3CR1 appears to be an important marker for distinct T cell memory subsets in mouse and human. We also explored the requirement for CX3CR1 in the generation of memory inflation in both MCMV and adenoviral models using Cx3cr1 gfp+/gfp+ mice. We showed that CX3CR1 is not required for memory inflation or conventional memory induction in the MCMV model. However, in the Ad-lacZ model, some blunting of memory cell frequencies and differentiation were seen following vaccination. Thus, CX3CR1 does not overall play a non-redundant role in memory formation, although the signal from the adenovirus-vector experiments suggests it may play a role in maintenance of inflated populations. This difference between the two models likely relates to the continuous replication of MCMV and the additional inflammatory responses. For example, MCMV-driven memory inflation is relatively unaffected by lack of CD4 + T cell help, whereas adenovirus-vector-induced memory is affected (Provine et al., 2014; Snyder et al., 2009) .
Although the human and mouse data are broadly consistent, we observed some differences. We distinguished three CX3CR1 subsets (neg, int, and hi) (Table S3) . (A) Composite FACS plots (n = 3) of A2-pp65 tetramer staining (left) of live CD3 + lymphocytes and CX3CR1 subsets (right) of A2-pp65 tetramer + CD8 + T cells.
Mean CMV tetramer + CD8 + T cell frequency and mean CX3CR1 subset frequency are indicated (n = 6).
(legend continued on next page) transition from CX3CR1 neg to CX3CR1 hi via CX3CR1 int maps onto other T cell differentiation markers in both cases, although the relationship is not exact and cells may transition from one state to another via distinct routes, leading to the continuum of differentiation observed using high-content cytometric approaches (Swadling et al., 2014; Wong et al., 2016 injected. Replication-deficient recombinant adenovirus expressed the b-galactosidase (b-gal) protein under the control of the HCMV promoter (AdlacZ) (Bolinger et al., 2013) . Ad-lacZ was propagated as previously described (Bolinger et al., 2013; Lee et al., 2017) .
Human Vaccination Protocols
The Ad6, ChAd3, and MVA vectors encoding the NS3-5B region of HCV genotype 1B (NSmut) based on sequence accession number M58335, and vaccination schedules have been described previously (Barnes et al., 2012; Swadling et al., 2014) (NCT: NCT01070407 and NCT01296451). All volunteers gave written informed consent before enrollment, and the studies were conducted according to the principles of the Declaration of Helsinki and in accordance with good clinical practice.
Detection and Analysis of Virus and Vaccine-Specific T Cells
Tetramers and pentamers are shown in Table S3 . Murine MHC class I monomers complexed with M38 (H-2Kb), M45 (H-2Db), b-gal D8V (H-2Kb), and I8V (H-2Kb) and some human MHC class I monomers (A2-pp65, A1-pp50, and B7-pp65) were tetramerized by addition of streptavidin-phycoerythrin (PE) (BD Biosciences) or streptavidin-APC (Invitrogen). Peptide was obtained from Proimmune (Oxford, UK). Aliquots of 100 mL of whole blood (mouse) or thawed 1 3 10 6 cells (human) were stained using a 50 mL solution of tetramers and CX3CR1 antibody at 37 C for 20 min followed by monoclonal antibody (mAb) staining. Human pentamer (A2-NS3 and A2-pp65; Proimmune, Oxford, UK) staining has been described previously (Swadling et al., 2014) .
Flow Cytometry Analysis and In Vivo Antibody Labeling Fluorochrome-conjugated antibodies are shown in Table S4 . For in vivo antibody labeling, mice were injected i.v. with 3 mg fluorochrome-conjugated anti-Thy1.2 (CD90.2) 10 min before tissue harvest, and lungs were perfused with 15 mL PBS. For intranuclear staining, surface-stained cells were fixed, washed, resuspended in permeabilization buffer (eBioscience FoxP3 staining kit), and stained with anti-T-bet and Eomes antibodies. Cells were analyzed by flow cytometry using a BD LSR II flow cytometer and FlowJo (Tree Star) and gated on viable leukocytes using live/dead fixable near-infra-red (IR) (Invitrogen). Composite flow cytometer plots were generated by randomly selecting equal numbers of each cell population of interest from each subject or from all cells from each subject for populations with low cell number (i.e., pentamer + cells).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (GraphPad, La Jolla, CA). The p values for comparison of means were determined by two-tailed t test and one-way and two-way ANOVA and were corrected using Holm-Sidak for multiple comparisons.
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